Showing results (4431-4440 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|October 4, 2005
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United KingdomErwin De Cock, John Hutton, Peter Canney, et al.Clinical Therapeutics|January 1, 1992
Influence on hormone levels, lipid metabolism and reversibility of endocrinological changes after leuprorelin acetate depot therapyK Bühler, U Winkler, A E SchindlerClinical Therapeutics|January 1, 1992
Formulation study of leuprorelin acetate to improve clinical performanceH ToguchiClinical Therapeutics|July 25, 2006
Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapiesCharles J Glueck, Dawit Aregawi, Mahlia Agloria, et al.Clinical Therapeutics|July 25, 2006
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthmaColin R Dormuth, Robert J Glynn, Peter Neumann, et al.Clinical Therapeutics|November 1, 1993
Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertensionD E Hilleman, S M Mohiuddin, B D Lucas, et al.Clinical Therapeutics|November 1, 1993
Quinapril in the treatment of hypertension in primary care centersL Alcocer, G Novoa, D SotresClinical Therapeutics|November 1, 1993
Effects of sevoflurane and halothane on reperfusion-induced arrhythmia in the isolated rat heartK Tanaka, M Nakamura, T Umeda, et al.Clinical Therapeutics|November 1, 1993
Patient adherence to prescribed potassium supplement therapyM T Halpern, D E Irwin, R E Brown, et al.Pageof 680